A study carried out at Moorfields Eye Hospital in London investigated enablers and barriers of engagement with app-based home monitoring of vision in patients with retinal diseases.
“The strongest predictor of uptake in our patient cohort was age, with older individuals relatively less likely to become active users, representing a risk factor for digital exclusion,” the authors wrote.
Better vision was positively associated with uptake and compliance.
The Home Vision Monitor app (HVM, Genentech) is an FDA-cleared, CE-marked self-test that uses shape discrimination hyperacuity to